Steller Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 04-07-2024
- Paid Up Capital ₹ 0.17 M
as on 04-07-2024
- Company Age 50 Year, 9 Months
- Last Filing with ROC 31 Mar 2007
- Open Charges ₹ 2.03 Cr
as on 04-07-2024
- Satisfied Charges ₹ 1.29 Cr
as on 04-07-2024
About Steller Pharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2007. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.17 M.
The company currently has active open charges totaling ₹2.03 Cr. The company has closed loans amounting to ₹1.29 Cr, as per Ministry of Corporate Affairs (MCA) records.
Himanshukumar Patel and Vipul Patel serve as directors at the Company.
- CIN/LLPIN
U24230MH1974PTC017279
- Company No.
017279
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 1974
- Date of AGM
29 Sep 2007
- Date of Balance Sheet
31 Mar 2007
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbai, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Steller Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshukumar Patel  | Director | 03-Apr-2000 | Current |
| Vipul Patel | Director | 02-Jul-1993 | Current |
Financial Performance of Steller Pharma.
Enhance accessibility to Steller Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Steller Pharma?
Unlock access to Steller Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Steller Mercantile Private LimitedActive 25 years 3 monthsHimanshukumar Patel and Vipul Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 21 Apr 2006 | ₹7.00 M | Open |
Union Bank Of India Creation Date: 21 Mar 2006 | ₹9.50 M | Open |
Gujarat State Financial Corporation Creation Date: 24 Feb 1994 | ₹3.84 M | Open |
How Many Employees Work at Steller Pharma?
Unlock and access historical data on people associated with Steller Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Steller Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Steller Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
